恆大高新(002591.SZ):前三季淨利預降56.77%-61.58%
格隆匯10月14日丨恆大高新(002591.SZ)發佈2020年三季度業績預告,前三季度歸屬於上市公司股東的淨利潤3200萬元-3600萬元,同比減少61.58%-56.77%;基本每股收益0.1066元-0.1199元。
第三季度歸屬於上市公司股東的淨利潤100萬元-500萬元,同比減少95.70%-78.49%;基本每股收益0.0033元-0.0167元。
由於受新冠肺炎疫情影響,本報告期營業收入比上年同期有所下滑,同時營業成本及費用等上升幅度較大,導致本報告期業績預計比上年同期有顯著下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.